This was somewhat surprising, given that i) the TGFβ pathway is considered to be a major driver of myofibroblast differentiation and ii) we confirmed the enrichment of the TGFβ gene signature in the SSc dermal fibroblast transcriptomes. This evidence concerns the gene TGFB1 and systemic sclerosis.